Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Breast Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Breast Neoplasm

Cancer Family

Breast Neoplasm

CI-CAN-00000007Explore in graph →

Non-malignant2,893 active trials43 approved drugs310 evidence items

NCIt: C2910
OncoTree: BNNOS
MeSH: D000069584
MeSH: D001943

Overview
Statistics
Survival
Genomics33
Variants & evidence310
Drugs79
Trials13863
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (266)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 10, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 251–266 of 266 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Wander, Seth A et al. Cancer Discov 2020
· 2020 · PMID 32404308 · validated cbioportal_study pubmed
Anurag, Meenakshi et al. Cancer discovery 2022
· 2022 · PMID 36001024 · validated cbioportal_study pubmed
Jiang, Yi-Zhou et al. Cell Research 2020
· 2020 · PMID 32719455 · validated cbioportal_study pubmed
Anders et al. J Immunother Cancer 2022
· 2022 · PMID 35121644 · validated cbioportal_study pubmed
Lefebvre et al. PLoS Med 2016
· 2016 · PMID 28027327 · validated cbioportal_study pubmed
Timothy M et al. J Pathol 2021
· 2021 · PMID 33263939 · validated cbioportal_study pubmed
Alison E et al. Nat Commun 2022
· 2022 · PMID 34795269 · validated cbioportal_study pubmed
Nixon et al. NPJ Breast Cancer 2019
· 2019 · PMID 31552290 · validated cbioportal_study pubmed
Fresia et al. Clinical Cancer Res 2020
· 2020 · PMID 32220886

Showing 251–266 of 266 publications

← Previous
1
…
10
11
Next →

· validated cbioportal_study

Stephens et al. Nature 2012

· 2012 · PMID 22722201 · validated cbioportal_study pubmed

Kan et al. Nature Communications 2018

· 2018 · PMID 29713003 · validated cbioportal_study pubmed

TCGA, Nature 2012

· 2012 · PMID 23000897 · validated cbioportal_study pubmed

TCGA, Cell 2015

· 2015 · PMID 26451490 · validated cbioportal_study pubmed

Gupta, Avantika et al. Nat Genet 2025

· 2025 · PMID 40379787 · validated cbioportal_study pubmed

Edaise M et al. NPJ Breast Cancer 2021

· 2021 · PMID 33863915 · validated cbioportal_study pubmed

TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses.

· Clin Exp Med · 2025 · PMID 41249701 · validated civic_curation pubmed